Biliary reflux; Long term; OAGB; One-anastomosis gastric bypass; QOL; Quality of life; Adult; Aged; Humans; Middle Aged; Quality of Life; Retrospective Studies; Young Adult; Diabetes Mellitus, Type 2; Gastric Bypass; Obesity, Morbid/surgery; Obesity, Morbid; Surgery; Endocrinology, Diabetes and Metabolism; Nutrition and Dietetics
Abstract :
[en] [en] BACKGROUND: One-anastomosis gastric bypass (OAGB) has gradually gained in popularity. Evidence of the validity of the technique and the quality of life in the longer term is scarce. The aim of this study was to retrospectively evaluate the longitudinal (≥ 5 years) safety, weight-loss efficacy, comorbid disease improvement, and quality of life of patients following OAGB.
METHODS: Data from patients who underwent OAGB from January 2009 to December 2011 were retrospectively reviewed. Preoperative clinical characteristics and data through 8 years were analyzed.
RESULTS: A total of 163 patients completed 5 to 8 years of follow-up with a mean age of 41 ± 11.4 years (22-65). Ninety-four patients (57.6%) had undergone prior bariatric surgery (gastric band). Mean body mass index (BMI, kg/m2) at the time of OAGB was 41.2 ± 6.5 (range 30.1-50.6). Twenty-one patients (13.0%) suffered from type 2 diabetes mellitus (T2DM), 59 (36.2%) hypertension, 31 osteoarthritis (19.0%), and 24 had obstructive sleep apnea (14.7%). At 5, 6, 7, and 8 years of follow-up, respective mean BMI reduction was 12.6 (n = 163), 11.8 (n = 100), 10.7 (n = 82), and 8.8 (n = 40). Respective mean excess weight loss was 81.8 ± 23.6%, 75.9 ± 20.8%, 69.1 ± 20.4%, and 62.3 ± 23.4%. All obesity-related comorbidities decreased significantly at follow-up time points. Five patients (3%) underwent laparoscopic reoperation within 90 days after surgery. Incidence of recurrent reflux was 14.0%. At a mean follow-up of 92 months (76-111), improved or greatly improved quality of life was reported by 86.0% of patients.
CONCLUSION: OAGB provided very good weight loss, comorbidity improvement, and quality of life at follow-up of ≥ 5 years.
Disciplines :
Surgery
Author, co-author :
Neuberg, Maud ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie abdo, sénologique, endocrine et de transplantation ; Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France. maud.neuberg@gmail.com
Blanchet, Marie-Cécile; Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France
Gignoux, Benoit; Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France
Frering, Vincent ; Clinique de la Sauvegarde, Espace Médico-Chirurgical, Immeuble Trait d'Union, Entrée A29, Av des Sources, 69009, Lyon, France
Language :
English
Title :
Long-Term Outcomes After One-Anastomosis Gastric Bypass (OAGB) in Morbidly Obese Patients.
Rutledge R. The mini-gastric bypass: experience with the first 1274 cases. Obes Surg. 2001;11(3):276–80.
Parmar CD, Mahawar KK. One-anastomosis (mini) gastric bypass is now an established bariatric procedure: a systematic review of 12,807 patients. Obes Surg. 2018;28(9):2956–67.
Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94.
Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini gastric bypass: a systematic review. Surg Obes Relat Dis. 2014;10:984–91.
De Luca M, Tie T, Ooi G, et al. Mini gastric bypass–one anastomosis gastric bypass (MGB-OAGB)–IFSO position statement. Obes Surg. 2018;28(5):1188–206.
Mahawar KK, Borg C-M, Kular KS, et al. Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg. 2017;27(9):2222–8.
Guirat A, Addossari HM. One anastomosis gastric bypass and risk of cancer. Obes Surg. 2018;28(5):1441–4.
Aggarwal S, Bhambri A, Singla V, et al. Adenocarcinoma of oesophagus involving gastro-oesophageal junction following mini-gastric bypass/one anastomosis gastric bypass. J Minim Access Surg. 2019; 10.4103/jmas.JMAS_320_18.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.
Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes. 2007;31(4):569–77.
NIH Consensus Development Conference Statement: gastrointestinal surgery for severe obesity. Obes Surg 1991;1:243-256.
Moorehead MK, Ardelt-Gattinger E, Lechner H, et al. The validation of the Moorehead-Ardelt quality of life questionnaire II. Obes Surg. 2003;13(5):684–92.
Felsenreich DM, Ladinig LM, Beckerhinn P, et al. Update: 10 years of sleeve gastrectomy—the first 103 patients. Obes Surg. 2018;28(11):3586–94.
Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: where do we go from here? World J Gastrointest Endosc. 2018;10(9):165–74.
Oor JE, Roks DJ, Ünlü C, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67.
Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.
Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;10:1749–56.
Parmar CD, Bryant C, Luque-DeLeon E, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m2: a systematic review comparing it with Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg 2019 Sep;29(9):3039-3046.
